Clinical Trial Update: Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2a study evaluating intravenous infusion of autologous osteoblastic cells in patients with severe osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• autologous osteoblastic cells

Snippet

Sponsor: Erasme University Hospital | Conditions: Severe Osteoporosis | Phase 2 | Status: COMPLETED